The Role of Early Hemoadsorption in Severe COVID-19 Treatment: A Pilot Randomized Controlled Trial
Based on our pilot randomized trial, the early application of HA-330 hemoadsorption in patients with severe COVID-19 may establish a favorable outcome in term of mortality. These data provide the initial proof of concept for conducting a large-scale study in the future.
Authors
- Karjbundid Surasit
- Nattachai Srisawat (ORCID: https://orcid.org/0000-0002-8544-8132)
Institutions
- Chulalongkorn University (TH)
- King Chulalongkorn Memorial Hospital (TH)
- The Royal College Of Anesthesiologists Of Thailand (TH)
- Office of the Royal Society
Publication Details
- Journal
- Blood Purification
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1159/000540584
- Citations
- 3
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 1.11